Editorial: KRAS in stage IV non-small cell lung cancer

Anneloes L. Noordhof, Torsten Gerriet Blum, Georgia Hardavella, Lizza E. L. Hendriks, Wouter H. van Geffen^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Keywords

@article{2d6a9948c9ed41cfb4e1e63f93ce5c3c,

title = "Editorial: KRAS in stage IV non-small cell lung cancer",

keywords = "KRAS G12C, KRAS inhibitors, Kirsten Rat Sarcoma (KRAS), lung adenocarcinoma, non-small cell lung cancer",

author = "Noordhof, {Anneloes L.} and Blum, {Torsten Gerriet} and Georgia Hardavella and Hendriks, {Lizza E. L.} and {van Geffen}, {Wouter H.}",

year = "2025",

month = mar,

day = "10",

doi = "10.3389/fonc.2024.1517049",

language = "English",

volume = "14",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial

T2 - KRAS in stage IV non-small cell lung cancer

AU - Noordhof, Anneloes L.

AU - Blum, Torsten Gerriet

AU - Hardavella, Georgia

AU - Hendriks, Lizza E. L.

AU - van Geffen, Wouter H.

PY - 2025/3/10

Y1 - 2025/3/10

KW - KRAS G12C

KW - KRAS inhibitors

KW - Kirsten Rat Sarcoma (KRAS)

KW - lung adenocarcinoma

KW - non-small cell lung cancer

U2 - 10.3389/fonc.2024.1517049

DO - 10.3389/fonc.2024.1517049

M3 - Editorial

SN - 2234-943X

VL - 14

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1517049

ER -